589
Views
46
CrossRef citations to date
0
Altmetric
Review Article

Cobalt and its compounds: update on genotoxic and carcinogenic activities

, &
Pages 522-539 | Received 27 Oct 2017, Accepted 17 Jun 2018, Published online: 11 Sep 2018

References

  • Alarifi S, Ali D, Al Omar Suliman, Y, Ahamed M, Siddiqui MA, Al-Khedhairy AA. 2013. Oxidative stress contributes to cobalt oxide nanoparticles-induced cytotoxicity and DNA damage in human hepatocarcinoma cells. Int J Nanomed. 8:189–199.
  • Annangi B, Bach J, Vales G, Rubio L, Marcos R, Hernandez A. 2015. Long-term exposures to low doses of cobalt nanoparticles induce cell transformation enhanced by oxidative damage. Nanotoxicol. 9:138–147.
  • Baldwin EL, Byl JA, Osheroff N. 2004. Cobalt enhances DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells. Biochemistry. 43:728–735.
  • Bastian S, Busch W, Kühnel D, Springer A, Meiszner T, Holke R, Scholz S, Iwe M, Pompe W, Gelinsky M, et al. 2009. Toxicity of tungsten carbide and cobalt-doped tungsten carbide nanoparticles in mammalian cells in vitro. Environ Health Perspect. 117:530–536.
  • Behl M, Stout MD, Herbert RA, Dill JA, Baker GL, Hayden BK, Roycroft JH, Bucher JR, Hooth MJ. 2015. Comparative toxicity and carcinogenicity of soluble and insoluble cobalt compounds. Toxicol. 333:195–205.
  • Beyersmann D, Hartwig A. 2008. Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch Toxicol. 82:493.
  • Bhabra G, Sood A, Fisher B, Cartwright L, Saunders M, Evans WH, Surprenant A, Lopez- Castejon G, Mann S, Davis SA, et al. 2009. Nanoparticles can cause DNA damage across a cellular barrier. Nature Nanotech. 4:876–883.
  • Bolt HM, Huici-Montagud A. 2008. Strategy of the scientific committee on occupational exposure limits (SCOEL) in the derivation of occupational exposure limits for carcinogens and mutagens. Arch Toxicol. 82:61–64.
  • Bradberry SM, Wilkinson JM, Ferner RE. 2014. Systemic toxicity related to metal hip prostheses. Clin Toxicol (Phila). 52:837–847.
  • Bresson C, Darolles C, Carmona A, Gautier C, Sage N, Roudeau S, Ortega R, Ansoborlo E, Malard V. 2013. Cobalt chloride speciation, mechanisms of cytotoxicity on human pulmonary cells, and synergistic toxicity with zinc. Metallomics. 5:133–143.
  • Brock T, Stopford W. 2003. Bioaccessibility of metals in human health risk assessment: evaluating risk from exposure to cobalt compounds. J Environ Monit. 5:71N–76N.
  • Bucher JR, Hailey JR, Roycroft JR, Haseman JK, Sills RC, Grumbein SL, Mellick PW, Chou BJ. 1999. Inhalation toxicity and carcinogenicity studies of cobalt sulfate. Toxicol Sci. 49:56–67.
  • Cavallo D, Ciervo A, Fresegna AM, Maiello R, Tassone P, Buresti G, Casciardi S, Iavicoli S, Ursini CL. 2015. Investigation on cobalt-oxide nanoparticles cyto-genotoxicity and inflammatory response in two types of respiratory cells. J Appl Toxicol. 35:1102–1113.
  • Cheung AC, Banerjee S, Cherian JJ, Wong F, Butany J, Gilbert C, Overgaard C, Syed K, Zywiel MG, Jacobs JJ, et al. 2016. Systemic cobalt toxicity from total hip arthroplasties: review of a rare condition Part 1 – history, mechanism, measurements, and pathophysiology. Bone Joint J. 98-B:6–13.
  • Christian WV, Oliver LD, Paustenbach DJ, Kreider ML, Finley BL. 2014. Toxicology-based cancer causation analysis of CoCr-containing hip implants: a quantitative assessment of genotoxicity and tumorigenicity studies. J Appl Toxicol. 34:939–967.
  • Collier CG, Pearce MJ, Hodgson A, Ball A. 1992. Factors affecting the in vitro dissolution of cobalt oxide. Environ Health Perspect. 97:109–113.
  • Colognato R, Bonelli A, Ponti J, Farina M, Bergamaschi E, Sabbioni E, Migliore L. 2008. Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro. Mutagenesis. 23:377–382.
  • Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. 2009. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 30:1073–1081.
  • Czarnek K, Terpiłowska S, Siwicki AK. 2015. Selected aspects of the action of cobalt ions in the human body. Cent Eur J Immunol. 40:236–242.
  • De Boeck M, Hoet P, Nemery B, Kirsch-Volders M, Lison D. 2003. In vivo genotoxicity of hard metal dust: induction of micronuclei in rat type II epithelial lung cells. Carcinogenesis. 24:1793–1800.
  • Devlin JJ, Pomerleau AC, Brent J, Morgan BW, Deitchman S, Schwartz M. 2013. Clinical features, testing, and management of patients with suspected prosthetic hip-associated cobalt toxicity: a systematic review of cases. J Med Toxicol. 9:405–415.
  • Ding M, Kisin ER, Zhao J, Bowman L, Lu Y, Jiang B, Leonard S, Vallyathan V, Castranova V, Murray AR, et al. 2009. Size-dependent effects of tungsten carbide-cobalt particles on oxygen radical production and activation of cell signaling pathways in murine epidermal cells. Toxicol Appl Pharmacol. 241:260–268.
  • Doherty AT, Howell RT, Ellis LA, Bisbinas I, Learmonth ID, Newson R, Case CP. 2001. Increased chromosome translocations and aneuploidy in peripheral blood lymphocytes of patients having revision arthroplasty of the hip. J Bone Joint Surg Br. 83-B:1075–1081.
  • Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, et al. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 107:43–54.
  • Farah SB. 1983. The in vivo effect of cobalt chloride on chromosomes. Rev Brasil Gen. 6:433.
  • Feng L, Zhang Y, Jiang M, Mo Y, Wan R, Jia Z, Tollerud DJ, Zhang X, Zhang Q. 2015. Up-regulation of Gadd45alpha after exposure to metal nanoparticles: the role of hypoxia inducible factor 1alpha. Environ Toxicol. 30:490–499.
  • Figgitt M, Newson R, Leslie IJ, Fisher J, Ingham E, Case CP. 2010. The genotoxicity of physiological concentrations of chromium (Cr(III) and Cr(VI)) and cobalt (Co(II)): an in vitro study. Mutat Res. 688:53–61.
  • Gil RA, Munoz AI. 2011. Influence of the sliding velocity and the applied potential on the corrosion and wear behavior of HC CoCrMo biomedical alloy in simulated body fluids. J Mech Behav Biomed Mater. 4:2090–2102.
  • Green SE, Luczak MW, Morse JL, DeLoughery Z, Zhitkovich A. 2013. Uptake, p53 pathway activation, and cytotoxic responses for Co(II) and Ni(II) in human lung cells: implications for carcinogenicity. Toxicol Sci. 136:467–477.
  • Greim H, Hartwig A, Reuter U, Richter-Reichhelm H-B, Thielmann H-W. 2009. Chemically induced pheochromocytomas in rats: mechanisms and relevance for human risk assessment. Crit Rev Toxicol. 39:695–718.
  • Grimsrud TK, Berge SR, Haldorsen T, Andersen A. 2005. Can lung cancer risk among nickel refinery workers be explained by occupational exposures other than nickel? Epidemiology. 16:146–154.
  • Hansen T, Clermont G, Alves A, Eloy R, Brochhausen C, Boutrand JP, Gatti AM, Kirkpatrick CJ. 2006. Biological tolerance of different materials in bulk and nanoparticulate form in a rat model: sarcoma development by nanoparticles. J R Soc Interface. 3:767–775.
  • Hartmann A, Hannemann F, Lutzner J, Seidler A, Drexler H, Gunther KP, Schmitt J. 2013. Metal ion concentrations in body fluids after implantation of hip replacements with metal-on-metal bearing–systematic review of clinical and epidemiological studies. PLoS One. 8:e70359.
  • Henderson RG, Verougstraete V, Anderson K, Arbildua JJ, Brock TO, Brouwers T, Cappellini D, Delbeke K, Herting G, Hixon G, et al. 2014. Inter-laboratory validation of bioaccessibility testing for metals. Regul Toxicol Pharmacol. 70:170–181.
  • Hillwalker WE, Anderson KA. 2014. Bioaccessibility of metals in alloys: evaluation of three surrogate biofluids. Environ Pollut. 185:52–58.
  • Hogstedt C, Alexandersson R. 1990. Mortality study among workers from the hard metal industry (in Swedish). Arbete Och Hälsa. 21:1–20.
  • Hong HH, Hoenerhoff MJ, Ton TV, Herbert RA, Kissling GE, Hooth MJ, Behl M, Witt KL, Smith-Roe SL, Sills RC, Pandiri AR. 2015. Kras, Egfr, and Tp53 Mutations in B6C3F1/N mouse and F344/NTac rat alveolar/bronchiolar carcinomas resulting from chronic inhalation exposure to cobalt metal. Toxicol Pathol. 43:872–882.
  • Hou L, Bowman L, Meighan TG, Shi X, Ding M. 2013. Induction of miR-21-PDCD4 signaling by tungsten carbide-cobalt nanoparticles in JB6 cells involves ROS-mediated MAPK pathways. J Environ Pathol Toxicol Oncol. 32:41–51.
  • Jantzen C, Jørgensen HL, Duus BR, Sporring SL, Lauritzen JB. 2013. Chromium and cobalt ion concentrations in blood and serum following various types of metal-on-metal hip arthroplasties: a literature overview. Acta Orthop. 84:229–236.
  • Jeong J, Han Y, Poland CA, Cho WS. 2015. Response-metrics for acute lung inflammation pattern by cobalt-based nanoparticles. Part Fibre Toxicol. 12:13–0089.
  • Jochmanova I, Yang C, Zhuang Z, Pacak K. 2013. Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst. 105:1270–1283.
  • Kasprzak KS, Zastawny TH, North SL, Riggs CW, Diwan BA, Rice JM, Dizdaroglu M. 1994. Oxidative DNA base damage in renal, hepatic, and pulmonary chromatin of rats after intraperitoneal injection of cobalt(II) acetate. Chem Res Toxicol. 7:329–335.
  • Keegan GM, Learmonth ID, Case CP. 2008. A systematic comparison of the actual, potential, and theoretical health effects of cobalt and chromium exposures from industry and surgical implants. Crit Rev Toxicol. 38:645–674.
  • Kirkland D, Brock T, Haddouk H, Hargeaves V, Lloyd M, Mc GS, Proudlock R, Sarlang S, Sewald K, Sire G, et al. 2015. New investigations into the genotoxicity of cobalt compounds and their impact on overall assessment of genotoxic risk. Regul Toxicol Pharmacol. 73:311–338.
  • Kuzyk PR, Sellan M, Olsen M, Schemitsch EH. 2011. Hip resurfacing versus metal-on- metal total hip arthroplasty – are metal ion levels different? Bull NYU Hosp Jt Dis. 69:S5–S11.
  • Ladon D, Doherty A, Newson R, Turner J, Bhamra M, Case CP. 2004. Changes in metal levels and chromosome aberrations in the peripheral blood of patients after metal-on-metal hip arthroplasty. J Arthroplasty. 19:78–83.
  • Lalmohamed A, Vestergaard P, de BA, Leufkens HG, van Staa TP, de VF. 2014. Changes in mortality patterns following total hip or knee arthroplasty over the past two decades: a nationwide cohort study. Arthritis Rheumatol. 66:311–318.
  • Lasfargues G, Wild P, Moulin JJ, Hammon B, Rosmorduc B, Rondeau du Noyer C, Lavandier M, Moline J. 1994. Lung cancer mortality in a French cohort of hard-metal workers. Am J Ind Med. 26:585–595.
  • Lee SG, Lee H, Rho HM. 2001. Transcriptional repression of the human p53 gene by cobalt chloride mimicking hypoxia. FEBS Lett. 507:259–263.
  • Li Q, Ke Q, Costa M. 2009. Alterations of histone modifications by cobalt compounds. Carcinogenesis. 7:1243–1251.
  • Lison D. (2015). Cobalt. In: Nordberg GF, Fowler BA, Nordberg M, editors. Handbook on the toxicology of metals. 4th ed. Academic Press; p. 743–763.
  • Lison D, Carbonnelle P, Mollo L, Lauwerys R, Fubini B. 1995. Physicochemical mechanism of the interaction between cobalt metal and carbide particles to generate toxic activated oxygen species. Chem Res Toxicol. 8:600–606.
  • Lison D, De Boeck M, Verougstraete V, Kirsch-Volders M. 2001. Update on the genotoxicity and carcinogenicity of cobalt compounds. Occup Environ Med. 58:619–625.
  • Liu LZ, Ding M, Zheng JZ, Zhu Y, Fenderson BA, Li B, Yu JJ, Jiang BH. 2015. Tungsten carbide-cobalt nanoparticles induce reactive oxygen species, AKT, ERK, AP-1, NF-kappaB, VEGF, and angiogenesis. Biol Trace Elem Res. 166:57–65.
  • Lombaert N, De Boeck M, Decordier I, Cundari E, Lison D, Kirsch-Volders M. 2004. Evaluation of the apoptogenic potential of hard metal dust (WC-Co), tungsten carbide and metallic cobalt. Toxicol Lett. 154:23–34.
  • Lombaert N, Lison D, Van Hummelen P, Kirsch-Volders M. 2008. In vitro expression of hard metal dust (WC-Co)–responsive genes in human peripheral blood mononucleated cells. Toxicol Appl Pharmacol. 227:299–312.
  • Madl AK, Kovochich M, Liong M, Finley BL, Paustenbach DJ, Oberdorster G. 2015a. Toxicology of wear particles of cobalt-chromium alloy metal-on-metal hip implants Part II: importance of physicochemical properties and dose in animal and in vitro studies as a basis for risk assessment. Nanomedicine. 11:1285–1298.
  • Madl AK, Liong M, Kovochich M, Finley BL, Paustenbach DJ, Oberdorster G. 2015b. Toxicology of wear particles of cobalt-chromium alloy metal-on-metal hip implants Part I: physicochemical properties in patient and simulator studies. Nanomedicine. 11:1201–1215.
  • Makela KT, Visuri T, Pulkkinen P, Eskelinen A, Remes V, Virolainen P, Junnila M, Pukkala E. 2012. Risk of cancer with metal-on-metal hip replacements: population based study. BMJ. 345:e4646.
  • Marsh GM, Buchanich JM, Zimmerman S. 2017. Mortality among hardmetal production workers: pooled analysis of cohort data from an international investigation. J Occup Environ Med. 59:e342–e364.
  • Mathew MT, Jacobs JJ, Wimmer MA. 2012. Wear-corrosion synergism in a CoCrMo hip bearing alloy is influenced by proteins. Clin Orthop Relat Res. 470:3109–3117.
  • Moche H, Chevalier D, Vezin H, Claude N, Lorge E, Nesslany F. 2015. Genotoxicity of tungsten carbide-cobalt (WC-Co) nanoparticles in vitro: mechanisms-of-action studies. Mutat Res Genet Toxicol Environ Mutagen. 779:15–22.
  • Moche H, Chevalier D, Barois N, Lorge E, Claude N, Nesslany F. 2014. Tungsten carbide-cobalt as a nanoparticulate reference positive control in in vitro genotoxicity assays. Toxicol Sci. 137:125–134.
  • Moulin JJ, Wild P, Romazini S, Lasfargues G, Peltier A, Bozec C, Deguerry P, Pellet F, Perdrix A. 1998. Lung cancer risk in hard-metal workers. Am J Epidemiol. 148:241–248.
  • NTP. 1998. NTP Toxicology and Carcinogenesis Studies of Cobalt Sulfate Heptahydrate (CAS No. 10026-24-1) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). Natl. Toxicol. Program. Tech. Rep. Ser. 471, 1–268.
  • NTP. 2014. NTP Toxicology Studies of Cobalt Metal (CASRN 7440-48-4) in F344/N Rats and B6C3F1/N Mice and Toxicology and Carcinogenesis Studies of Cobalt Metal in F344/NTac Rats and B6C3F1/N Mice (Inhalation Studies). Peer review draft. Technical Reports Series 581. Research Triangle Park, NC, US Department of Health and Human Services, NIH.
  • Onega T, Baron J, MacKenzie T. 2006. Cancer after total joint arthroplasty: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 15:1532–1537.
  • Ortega R, Bresson C, Darolles C, Gautier C, Roudeau S, Perrin L, Janin M, Floriani M, Aloin V, Carmona A, et al. 2014. Low-solubility particles and a Trojan-horse type mechanism of toxicity: the case of cobalt oxide on human lung cells. Part Fibre Toxicol. 11:14.
  • Ozaki K, Haseman JK, Hailey JR, Maronpot RR, Nyska A. 2002. Association of adrenal pheochromocytoma and lung pathology in inhalation studies with particulate compounds in the male F344 rat–the National Toxicology Program experience. Toxicol Pathol. 30:263–270.
  • Paget V, Moche H, Kortulewski T, Grall R, Irbah L, Nesslany F, Chevillard S. 2015. Human cell line-dependent WC-Co nanoparticle cytotoxicity and genotoxicity: a key role of ROS production. Toxicol Sci. 143:385–397.
  • Pahuta M, Smolders JM, van Susante JL, Peck J, Kim PR, Beaule PE. 2016. Blood metal ion levels are not a useful test for adverse reactions to metal debris: a systematic review and meta-analysis. Bone Joint Res. 5:379–386.
  • Palit S, Sharma A, Talukder G. 1991. Chromosomal aberrations induced by cobaltous chloride in mice in vivo. Biol Trace Elem Res. 29:139–145.
  • Papageorgiou I, Brown C, Schins R, Singh S, Newson R, Davis S, Fisher J, Ingham E, Case CP. 2007a. The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials. 28:2946–2958.
  • Papageorgiou I, Yin Z, Ladon D, Baird D, Lewis AC, Sood A, Newson R, Learmonth ID, Case CP. 2007b. Genotoxic effects of particles of surgical cobalt chrome alloy on human cells of different age in vitro. Mutat Res. 619:45–58.
  • Patel E, Lynch C, Ruff V, Reynolds M. 2012. Co-exposure to nickel and cobalt chloride enhances cytotoxicity and oxidative stress in human lung epithelial cells. Toxicol Appl Pharmacol. 258:367–375.
  • Paustenbach DJ, Tvermoes BE, Unice KM, Finley BL, Kerger BD. 2013. A review of the health hazards posed by cobalt. Crit Rev Toxicol. 43:316–362.
  • Pijls BG, Meessen JM, Schoones JW, Fiocco M, van der Heide HJ, Sedrakyan A, Nelissen RG. 2016. Increased mortality in metal-on-metal versus non-metal-on-metal primary total hip arthroplasty at 10 years and longer follow-up: a systematic review and meta- analysis. PLoS One. 11:e0156051.
  • Pilger A, Schaffer A, Rudiger HW, Osterode W. 2002. Urinary 8-hydroxydeoxyguanosine and sister chromatid exchanges in patients with total hip replacements. J Toxicol Environ Health Part A. 65:655–664.
  • Piret JP, Mottet D, Raes M, Michiels C. 2002. CoCl2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann N Y Acad Sci. 973:443–447.
  • Proper SP, Saini Y, Greenwood KK, Bramble LA, Downing NJ, Harkema JR, LaPres JJ. 2014. Loss of hypoxia-inducible factor 2 alpha in the lung alveolar epithelium of mice leads to enhanced eosinophilic inflammation in cobalt-induced lung injury. Toxicol Sci. 137:447–457.
  • Raghunathan VK, Devey M, Hawkins S, Hails L, Davis SA, Mann S, Chang IT, Ingham E, Malhas A, Vaux DJ, et al. 2013. Influence of particle size and reactive oxygen species on cobalt chrome nanoparticle-mediated genotoxicity. Biomaterials. 34:3559–3570.
  • Reinardy HC, Syrett JR, Jeffree RA, Henry TB, Jha AN. 2013. Cobalt-induced genotoxicity in male zebrafish (Danio rerio), with implications for reproduction and expression of DNA repair genes. Aquat Toxicol. 126:224–230.
  • Sadiq K, Stack MM, Black RA. 2015. Wear mapping of CoCrMo alloy in simulated bio-tribocorrosion conditions of a hip prosthesis bearing in calf serum solution. Mater Sci Eng C Mater Biol Appl. 49:452–462.
  • Saini Y, Proper SP, Dornbos P, Greenwood KK, Kopec AK, Lynn SG, Grier E, Burgoon LD, Zacharewski TR, Thomas RS, et al. 2015. Loss of HIF-2alpha rescues the HIF-1alpha deletion phenotype of neonatal respiratory distress in mice. PLoS One. 10:e0139270.
  • Saini Y, Kim KY, Lewandowski R, Bramble LA, Harkema JR, Lapres JJ. 2010. Role of hypoxia-inducible factor 1{alpha} in modulating cobalt-induced lung inflammation. Am J Physiol Lung Cell Mol Physiol. 298:L139–L147.
  • Sauni R, Oksa P, Uitti J, Linna A, Kerttula R, Pukkala E. 2017. Cancer incidence among Finnish male cobalt production workers in 1969-2013: a cohort study. BMC Cancer. 17:340.
  • Schins RP, F, Knaapen Ag1054:427M. 2007. Genotoxicity of poorly soluble particles. Inhal Toxicol. 19:189–198.
  • Simonsen LO, Brown AM, Harbak H, Kristensen BI, Bennekou P. 2011. Cobalt uptake and binding in human red blood cells. Blood Cells Mol Dis. 46:266–276.
  • Simonsen LO, Harbak H, Bennekou P. 2012. Cobalt metabolism and toxicology-a brief update. Sci Total Environ. 432:210–215.
  • Smith AJ, Dieppe P, Porter M, Blom AW. 2012. Risk of cancer in first seven years after metal-on-metal hip replacement compared with other bearings and general population: linkage study between the National Joint Registry of England and Wales and hospital episode statistics. Brit Med J. 344:e2383.
  • Smith LJ, Holmes AL, Kandpal SK, Mason MD, Zheng T, Wise JP. Sr. 2014. The cytotoxicity and genotoxicity of soluble and particulate cobalt in human lung fibroblast cells. Toxicol Appl Pharmacol. 278:259–265.
  • Speer RM, The T, Xie H, Liou L, Adam RM, Wise JP Sr. 2017. The cytotoxicity and genotoxicity of particulate and soluble cobalt in human urothelial cells. Biol Trace Elem Res. 180:48–55.
  • Stopford W, Turner J, Cappellini D, Brock T. 2003. Bioaccessibility testing of cobalt compounds. J Environ Monit. 5:675–680.
  • Suzuki Y, Shimizu H, Nagae Y, Fukumoto M, Okonogi H, Kadokura M. 1993. Micronucleus test and erythropoiesis: effect of cobalt on the induction of micronuclei by mutagens. Environ Mol Mutagen. 22:101–106.
  • Tsaousi A, Jones E, Case CP. 2010. The in vitro genotoxicity of orthopaedic ceramic (Al2O3) and metal (CoCr alloy) particles. Mutat Res. 697:1–9.
  • Uboldi C, Orsière T, Darolles C, Aloin V, Tassistro V, George I, Malard V. 2015. Poorly soluble cobalt oxide particles trigger genotoxicity via multiple pathways. Toxicol Sci. 13:870.
  • Visuri T, Pulkkinen P, Paavolainen P, Pukkala E. 2010. Cancer risk is not increased after conventional hip arthroplasty. Acta Orthop. 81:77–81.
  • Wild P, Bourgkard E, Paris C. 2009. Lung cancer and exposure to metals: the epidemiological evidence. Methods Mol Biol. 472:139–167.
  • Wild P, Perdrix A, Romazini S, Moulin JJ, Pellet F. 2000. Lung cancer mortality in a site producing hard metals. Occup Environ Med. 57:568–573.
  • Xie H, Smith LJ, Holmes AL, Zheng T, Pierce Wise JP. Sr. 2016. The cytotoxicity and genotoxicity of soluble and particulate cobalt in human lung epithelial cells. Environ Mol Mutagen. 57:282–287.
  • Yuan Y, Hilliard G, Ferguson T, Millhorn DE. 2003. Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha. J Biol Chem. 278:15911–15916.
  • Zhang XD, Zhao J, Bowman L, Shi X, Castranova V, Ding M. 2010. Tungsten carbide-cobalt particles activate Nrf2 and its downstream target genes in JB6 cells possibly by ROS generation. J Environ Pathol Toxicol Oncol. 29:31–40.
  • Zhao J, Bowman L, Magaye R, Leonard SS, Castranova V, Ding M. 2013. Apoptosis induced by tungsten carbide-cobalt nanoparticles in JB6 cells involves ROS generation through both extrinsic and intrinsic apoptosis pathways. Int J Oncol. 42:1349–1359.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.